Optimizing the anticoagulation therapy is of pivotal importance in patients with a malignant
tumor, as venous thromboembolism (VTE) has become the second-leading cause of death …

The thrombosis-related diseases are one of the leading causes of illness and death in the
general population, and despite significant improvements in long-term survival due to …

Background: Cardiovascular disease is a global health concern and reducing plasma LDL-
C levels is a major goal in cardiovascular prevention. Our study aimed to evaluate the …

Atherosclerosis is the chronic pathophysiological substrate for coronary artery disease
(CAD) and peripheral artery disease (PAD), and its many clinical consequences, which …

The dual pathway inhibition (DPI) with low dose rivaroxaban and aspirin in patients with
stable atherosclerotic vascular disease reduced the occurrence of cardiovascular (CV) …

Aspirin is a non-steroidal anti-inflammatory drug. It blocks prostaglandin (PG) production by
inhibiting cyclooxygenase 1 (COX-1) and COX-2 activity. There is now significant evidence …

Cardiovascular disease (CVD) is a widespread condition and the primary cause of death
worldwide, responsible for 17.9 million fatalities annually, with this number expected to …